Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12452413 | 0.92 | RXFP1 (0.41) | KMT2AMEN1SMN1; SMN2L3MBTL1POLB | |
| SCHEMBL12452412 | 0.86 | SMN1; SMN2 (0.49) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL1753752 | 0.86 | MEN1 (0.51) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL12848669 | 0.86 | MEN1 (0.51) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL19154684 | 0.83 | SMN1; SMN2 (0.46) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL19901428 | 0.83 | MEN1 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL1753582 | 0.83 | MEN1 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL13596299 | 0.83 | MEN1 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL13596292 | 0.83 | MEN1 (0.54) | KMT2AMEN1SMN1; SMN2L3MBTL1NAMPT | |
| SCHEMBL22106658 | 0.81 | KMT2A (0.58) | KMT2AMEN1SMN1; SMN2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065767-A1 | Substituted CC-1065 Analogs and Their Conjugates | SYNTARGA B.V. (NL) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065767-A1 | Substituted CC-1065 Analogs and Their Conjugates | PCNA, TOP1, TOP2B | KMT2A 829/4885MEN1 1107/4885SMN1; SMN2 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.